tiprankstipranks
Alzamend Neuro (DE:9ZT)
HAMBURG:9ZT
Germany Market
9ZT
Alzamend Neuro
RESEARCH TOOLSreports

Alzamend Neuro (9ZT) Financial Statements

2 Followers

Alzamend Neuro Financial Overview

Alzamend Neuro's market cap is currently €7.16M. The company's EPS TTM is €; its P/E ratio is -0.75; Alzamend Neuro is scheduled to report earnings on ―, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Apr 26Apr 25Apr 24Apr 23Apr 22
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -8.77M$ -4.50M$ -9.94M$ -14.87M$ -12.32M
EBITDA$ -8.66M$ -4.45M$ -9.89M$ -14.85M$ -12.31M
Net Income$ -8.77M$ -4.51M$ -9.95M$ -14.88M$ -12.36M
Balance Sheet
Cash & Short-Term Investments$ 710.69K$ 3.95M$ 376.05K$ 5.14M$ 14.06M
Total Assets$ 2.08M$ 4.60M$ 631.59K$ 5.92M$ 14.52M
Total Debt$ 0.00$ 0.00$ 300.71K$ 0.00$ 0.00
Net Debt$ -710.69K$ -3.95M$ -75.33K$ -5.14M$ -14.06M
Total Liabilities$ 1.35M$ 634.76K$ 3.23M$ 2.87M$ 1.16M
Stockholders' Equity$ 733.21K$ 3.97M$ -2.59M$ 3.05M$ 13.35M
Cash Flow
Free Cash Flow$ -8.07M$ -6.87M$ -8.42M$ -8.92M$ -6.72M
Operating Cash Flow$ -8.07M$ -6.57M$ -8.27M$ -8.92M$ -6.61M
Investing Cash Flow$ 0.00$ -300.00K$ -147.24K$ 0.00$ -106.46K
Financing Cash Flow$ 4.83M$ 10.44M$ 3.65M$ 200.00$ 18.85M
Currency in USD

Alzamend Neuro Earnings and Revenue History

Income Statement >

Alzamend Neuro Debt to Assets

Balance Sheet >

Alzamend Neuro Cash Flow

Cash Flow >

Alzamend Neuro Forecast EPS vs Actual EPS

Earnings >